Context Therapeutics Inc. - Common Stock (CNTX)
CUSIP: 21077P108
Q3 2025 13F Holders as of 30 Sep 2025
- Type / Class
- Equity / Common Stock
- Shares outstanding
- 91,741,639
- Total 13F shares
- 68,966,266
- Share change
- +361,686
- Total reported value
- $66,815,968
- Price per share
- $0.97
- Number of holders
- 37
- Value change
- +$689,909
- Number of buys
- 12
- Number of sells
- 14
Quarterly Holders Quick Answers
What is CUSIP 21077P108?
CUSIP 21077P108 identifies CNTX - Context Therapeutics Inc. - Common Stock in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 21077P108:
Top shareholders of CNTX - Context Therapeutics Inc. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| MPM BioImpact LLC |
13F
|
Company |
16%
|
14,705,882
|
$9,635,294 | — | 30 Jun 2025 | |
| Deep Track Capital, LP |
13D/G
13F
|
Company |
8.3%
|
7,419,355
|
$7,419,355 | $0 | 31 Mar 2025 | |
| Avidity Partners Management LP |
13F
|
Company |
8.2%
|
7,477,255
|
$4,899,097 | — | 30 Jun 2025 | |
| Nextech Invest, Ltd. |
13F
|
Company |
8.1%
|
7,419,355
|
$4,861,161 | — | 30 Jun 2025 | |
| Blue Owl Capital Holdings LP |
13F
|
Company |
8.1%
|
7,407,906
|
$4,853,660 | — | 30 Jun 2025 | |
| FRANKLIN RESOURCES INC |
13D/G
13F
|
Company |
4.5%
|
4,003,380
|
$4,003,380 | $0 | 31 Mar 2025 | |
| GREAT POINT PARTNERS LLC |
13F
|
Company |
5.1%
|
4,683,711
|
$3,068,767 | — | 30 Jun 2025 | |
| VANGUARD GROUP INC |
13F
|
Company |
3.7%
|
3,360,582
|
$2,201,181 | — | 30 Jun 2025 | |
| Blackstone Inc. |
13F
|
Company |
2.7%
|
2,440,330
|
$1,598,904 | — | 30 Jun 2025 | |
| Martin A. Lehr |
13D/G
|
Martin Lehr |
2.1%
|
1,595,742
|
$1,595,742 | $0 | 31 Dec 2024 | |
| Nantahala Capital Management, LLC |
13F
|
Company |
2.1%
|
1,935,484
|
$1,268,129 | — | 30 Jun 2025 | |
| Alyeska Investment Group, L.P. |
13F
|
Company |
1.8%
|
1,663,355
|
$1,089,830 | — | 30 Jun 2025 | |
| Sio Capital Management, LLC |
13F
|
Company |
1.5%
|
1,341,636
|
$879,040 | — | 30 Jun 2025 | |
| BlackRock, Inc. |
13F
|
Company |
0.93%
|
848,970
|
$556,245 | — | 30 Jun 2025 | |
| Woodline Partners LP |
13F
|
Company |
0.74%
|
680,188
|
$445,659 | — | 30 Jun 2025 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.7%
|
637,810
|
$418,084 | — | 30 Jun 2025 | |
| Affinity Asset Advisors, LLC |
13F
|
Company |
0.56%
|
518,025
|
$339,410 | — | 30 Jun 2025 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
0.4%
|
363,930
|
$238,447 | — | 30 Jun 2025 | |
| ADAR1 Capital Management, LLC |
13F
|
Company |
0.38%
|
351,094
|
$230,037 | — | 30 Jun 2025 | |
| LUMINUS MANAGEMENT LLC |
13F
|
Company |
0.36%
|
328,222
|
$215,051 | — | 30 Jun 2025 | |
| STATE STREET CORP |
13F
|
Company |
0.17%
|
152,607
|
$99,988 | — | 30 Jun 2025 | |
| Walleye Capital LLC |
13F
|
Company |
0.14%
|
132,786
|
$87,001 | — | 30 Jun 2025 | |
| HighTower Advisors, LLC |
13F
|
Company |
0.14%
|
125,852
|
$82,458 | — | 30 Jun 2025 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.12%
|
113,565
|
$74,408 | — | 30 Jun 2025 | |
| Qube Research & Technologies Ltd |
13F
|
Company |
0.12%
|
106,779
|
$69,962 | — | 30 Jun 2025 | |
| Mill Creek Capital Advisors, LLC |
13F
|
Company |
0.11%
|
104,631
|
$68,554 | — | 30 Jun 2025 | |
| Velan Capital Investment Management LP |
13F
|
Company |
0.11%
|
100,000
|
$65,520 | — | 30 Jun 2025 | |
| Clear Harbor Asset Management, LLC |
13F
|
Company |
0.06%
|
57,804
|
$37,873 | — | 30 Jun 2025 | |
| GTS SECURITIES LLC |
13F
|
Company |
0.05%
|
44,176
|
$28,935 | — | 30 Jun 2025 | |
| Cerity Partners LLC |
13F
|
Company |
0.02%
|
20,000
|
$13,104 | — | 30 Jun 2025 | |
| CAXTON CORP |
13F
|
Company |
0.02%
|
18,403
|
$12,058 | — | 30 Jun 2025 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.02%
|
17,067
|
$11,182 | — | 30 Jun 2025 | |
| CW Advisors, LLC |
13F
|
Company |
0.02%
|
15,000
|
$9,828 | — | 30 Jun 2025 | |
| Tarek Sahmoud |
3/4/5
|
Chief Medical Officer |
—
mixed-class rows
|
35,000
mixed-class rows
|
$8,415 | — | 16 Aug 2022 | |
| OSAIC HOLDINGS, INC. |
13F
|
Company |
0.01%
|
10,500
|
$6,827 | — | 30 Jun 2025 | |
| Tower Research Capital LLC (TRC) |
13F
|
Company |
0.01%
|
7,414
|
$4,858 | — | 30 Jun 2025 | |
| MORGAN STANLEY |
13F
|
Company |
0%
|
3,500
|
$2,293 | — | 30 Jun 2025 | |
| Newbridge Financial Services Group, Inc. |
13F
|
Company |
0%
|
2,000
|
$1,310 | — | 30 Jun 2025 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0%
|
543
|
$356 | — | 30 Jun 2025 | |
| UBS Group AG |
13F
|
Company |
0%
|
370
|
$242 | — | 30 Jun 2025 | |
| SBI Securities Co., Ltd. |
13F
|
Company |
0%
|
113
|
$74 | — | 30 Jun 2025 | |
| Ullmann Claudio Dansky |
3/4/5
|
Chief Medical Officer |
—
class O/S missing
|
174,960
|
— | — | 13 Feb 2025 | |
| Andy Pasternak |
3/4/5
|
Director |
—
class O/S missing
|
138,900
|
— | — | 12 Jun 2025 | |
| Jennifer Evans Stacey |
3/4/5
|
Director |
—
class O/S missing
|
123,500
|
— | — | 12 Jun 2025 | |
| Karen L. Smith |
3/4/5
|
Director |
—
class O/S missing
|
123,500
|
— | — | 12 Jun 2025 | |
| Linda West |
3/4/5
|
Director |
—
class O/S missing
|
123,500
|
— | — | 12 Jun 2025 | |
| Luke Nathaniel Walker |
3/4/5
|
Director |
—
class O/S missing
|
123,500
|
— | — | 12 Jun 2025 | |
| Philip W. Kantoff |
3/4/5
|
Director |
—
class O/S missing
|
123,500
|
— | — | 12 Jun 2025 | |
| Richard J. Berman |
3/4/5
|
Director |
—
class O/S missing
|
50,000
|
— | — | 13 Jun 2024 | |
| Evan G. Dick |
3/4/5
|
Former Section 16 officer |
—
class O/S missing
|
29,223
|
— | — | 15 Feb 2022 |
Institutional Holders of Context Therapeutics Inc. - Common Stock (CNTX) as of Q3 2025
As of 30 Sep 2025,
Context Therapeutics Inc. - Common Stock (CNTX) was held by
37 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
68,966,266 shares.
The largest 10 holders included
MPM BIOIMPACT LLC, Avidity Partners Management LP, Nextech Invest, Ltd., Deep Track Capital, LP, Blue Owl Capital Holdings LP, GREAT POINT PARTNERS LLC, FRANKLIN RESOURCES INC, VANGUARD GROUP INC, Blackstone Inc., and Alyeska Investment Group, L.P..
This page lists
37
institutional shareholders reporting positions in this security
for the Q3 2025 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q3 2025 vs Q2 2025 Across Filers
Q2 2025 holders
39
Q3 2025 holders
37
Holder diff
-2
| Investor | Q2 2025 Shares | Q3 2025 Shares | Share Diff | Share Chg % | Q2 2025 Value $ | Q3 2025 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.